# Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications

> **NCT05942066** · — · RECRUITING · sponsor: **Tethis S.p.A.** · enrollment: 200 (estimated)

## Conditions studied

- Healthy Participants

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT05942066
- **Lead sponsor:** Tethis S.p.A.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2023-10-09
- **Primary completion:** 2027-07
- **Final completion:** 2027-07
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2026-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05942066

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05942066, "Feasibility Study Aiming at Pre-Analytical Standardization of Whole Blood Processing for Liquid Biopsy Applications". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05942066. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*